Pharmaceutical Business review

FDA approves Mylan Gabapentin capsules

Matrix Laboratories, a subsidiary of Mylan, claims Gabapentin capsules USP are the genereic version of Pfizer’s treatment for painful complication of shingles, Neurontin capsules.

Gabapentin capsule is an anticonvulsant. The inactive ingredients for the capsules are corn starch and talc.

The company said that it will be launching the product immediately.